Advertisement
Brief report| Volume 37, ISSUE 6, P414-416, March 15, 1995

Serotonergic responsivity in trichotillomania: Neuroendrocrine effects of m-chlorophenylpiperazine

      This paper is only available as a PDF. To read, Please Download here.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Carlsson M
        • Svensson K
        • Erikson E
        • Carlsson A
        Rat brain serotonin: biochemical and functional evidence for a sex difference.
        J Neural Transm. 1985; 63: 297-313
        • Charney DS
        • Goodman WK
        • Price LH
        • Woods SW
        • Rasmussen SA
        • Heninger RA
        Serotonin function in obsessive-compulsive disorder: A comparison of the effects of tryptophan and m-chlorophenylpiperazine in patients and healthy subjects.
        Arch Gen Psychiatry. 1988; 45: 177-185
        • Christenson GA
        • Mackenzie TB
        • Mitchell JE
        Characteristics of 60 adult chronic hair pullers.
        Am J Psychiatry. 1991; 148: 365-370
        • Christenson GA
        • Mackenzie TB
        • Mitchell JE
        • Callies AL
        A placebo-controlled, double-blind crossover study of fluoxetine in trichotillomania.
        Am J Psychiatry. 1991; 148: 1566-1571
        • Hollander E
        • DeCaria C
        • Gulley R
        • et al.
        Effects of chronic fluoxetine treatment on behavioral and neuroendocrine response to meta-chlorophenylpiperazine in obsessive-compulsive disorder.
        Psychiatry Res. 1991; 36: 1-17
        • Hollander E
        • DeCaria C
        • Nitescu A
        • et al.
        Serotonergic function in obsessive compulsive disorder: Behavioral and neuroendocrine responses to oral m-CPP and fenfluramine in patients and healthy volunteers.
        Arch Gen Psychiatry. 1992; 49: 21-28
        • Hollander E
        • Stein DJ
        • DeCaria CM
        • Saoud JB
        • Klein DF
        • Liebowitz MR
        A pilot study of biological predictors of treatment outcome in obsessive-compulsive disorder.
        Biological Psychiatry. 1993; 33: 747-749
      1. Hollander E Obsessive-Compulsive Related Disorders. American Psychiatric Press, Budapest, Hungary Academy of Science Publications1993
        • Hollander E
        • Stein DJ
        • DeCaria CM
        • et al.
        Serotonergic sensitivity in borderline personality disorder: Preliminary findings.
        Am J Psychiatry. 1994; 151: 277-280
        • Jenike MA
        Obsessive-compulsive and related disorders: A hidden epidemic.
        New Engl J Med. 1989; 321: 539-541
        • Munaro NI
        The effect of ovarian steroids on hypothalamic 5-hydroxytryptamine neuronal activity.
        Neuroendocrinology. 1978; 26: 270-276
        • Pigott TA
        • Hill JL
        • Grady TA
        • et al.
        A comparison of the behavioral effects of oral versus intravenous mCPP administration in OCD patients and the effect of metergoline prior to iv mcpp.
        Biol Psychiatry. 1992; 33: 3-14
        • Pollard CA
        • Ibe IO
        • Krojanker DN
        • Kitchen AD
        • Bronson SS
        • Flynn TM
        Clomipramine treatment of trichotillomania: a follow-up report on four cases.
        J Clin Psychiatry. 1991; 52: 128-130
        • Rettew DC
        • Cheslow DL
        • Rapoport JL
        • et al.
        Neuropsychological test performance in trichotillomania: A further link with obsessive-compulsive disorder.
        J Anxiety Disord. 1991; 5: 225-235
        • Stein DJ
        • Hollander E
        The spectrum of obsessive-compulsive related disorders.
        in: Hollander E Obsessive-Compulsive Related Disorders. American Psychiatric Press, Washington DC1993
        • Stein DJ
        • Hollander E
        • Cohen L
        • Simeon D
        • DeCaria CM
        • Islam MN
        Pharmacological Challenges in Trichotillomania.
        in: Presented at the Annual Meeting of the American Psychiatric Association, 19941994
        • Swedo SE
        • Leonard HL
        • Rapoport JL
        • Lenane MC
        • Goldberger EL
        • Cheslow DL
        A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania (hair pulling).
        N Engl M Med. 1989; 321: 497-501
        • Swedo SE
        • Rapoport JL
        • Leonard HL
        • Schapiro MB
        • Rapoport SI
        • Grady CL
        Regional cerebral glucose metabolism of women with trichotillomania.
        Arch Gen Psychiatry. 1991; 48: 828-833
        • Thoren P
        • Asberg M
        • Bertilsson L
        • Mellstrom B
        • Sjoqvist F
        • Traskman L
        Clomipramine treatment of obsessive-compulsive disorder, I: a controlled clinical trial.
        Arch Gen Psychiatry. 1980; 37: 1281-1285
        • Zohar J
        • Insel TR
        Obsessive-Compulsive disorder: Psychobiological approaches to diagnosis, treatment, and pathophysiology.
        Biol Psychiatry. 1987; 22: 667-687
        • Zohar J
        • Mueller EA
        • Insel T
        • Insel R
        • Zohar-Kadouch RC
        • Murphy DL
        Serotonergic responsivity in obsessive-compulsive disorder: Comparison of patients and healthy controls.
        Arch Gen Psychiatry. 1987; 44: 946-951